Though no results related to T cell lymphoma patients have been posted as of now, preclinical data showed that HDAC inhibition increased levels of T cell chemoattractants and MDSC infiltration in multiple lung adenocarcinoma models. The gene discussed is HDAC9; the disease is T-cell non-Hodgkin lymphoma.